Predictive and presymptomatic testing can have a profound impact on public health by enabling early detection and prevention of diseases. For example, identifying individuals at high risk for cardiovascular disease can lead to early interventions such as lifestyle modifications and medication, ultimately reducing the incidence and severity of heart disease. These tests also facilitate the development of personalized medicine, where treatments are tailored to an individual's genetic profile, improving outcomes and reducing adverse effects.
